VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge 100% Glistening-Free IOL Material.

In a statement, Andreas Kühnel, the Managing Director at VSY Biotechnology GmbH, expressed his excitement about the groundbreaking innovation, saying, "This innovative solution, developed in-house, marks a significant leap forward in intraocular lens (IOL) development, providing a game-changing answer to the long-standing challenge of glistenings. By addressing this issue, VSY Biotechnology's Glistening-Free IOL Material has the potential to revolutionize cataract surgery, bringing about substantial improvements in visual clarity and surgical precision."

Glistenings, microscopic fluid-filled microbubbles within IOLs, have posed a significant challenge for patients undergoing cataract surgery. These glistenings cause light scattering, resulting in reduced contrast sensitivity, visual acuity, and the appearance of unwanted optical artifacts. Over time, these visual disturbances can degrade a patient's quality of vision and cause dissatisfaction with the procedure.

Through its diligent efforts, VSY Biotechnology has effectively overcome this issue using its in-house production capabilities, setting it apart from other global biotechnology companies whose IOLs are impeded by glistening-related concerns.

VSY Biotechnology's 100% Glistening-Free IOL Material offers a unique composition that sets it apart from conventional IOL materials. The key to its success lies in its ability to achieve Zero Glistening even under the most extreme conditions.

The Enova® IOLs crafted using 100% Glistening-Free IOL Material present a multitude of advantages for patients and surgeons such as:

  1. Enhanced Visual Acuity: By eliminating glistenings, these IOLs provide patients with improved visual acuity and enhanced contrast sensitivity. The result is a more vivid and crisp vision, elevating the overall quality of life post-cataract surgery.
  2. Reliable Long-Term Stability: The controlled water uptake capability of the Glistening-Free IOL Material ensures uniform hydration at specific sites, effectively resisting glistening formation over time. This translates into consistent visual performance and long-lasting stability for patients.
  3. Improved Surgical Outcomes: Thanks to the low glass transition temperature (Tg −2.0°C) and optimized modulus of elasticity, surgeons benefit from greater flexibility and controlled unfolding during the implantation process. This enhancement streamlines surgical procedures and enhances patient comfort.

The efficacy of VSY Biotechnology's Glistening-Free IOL Material has been rigorously tested and validated through comprehensive studies, including the glistening study at the Intermountain Ocular Research Center (Mamalis/Werner Laboratory), John A. Moran Eye Center, University of Utah. The results showcased the superiority of the 100% Glistening-Free Enova® IOL Material, highlighting its ability to outperform traditional IOLs with Zero Glistening and Zero Haze.1

The 100% Glistening-Free IOL Material epitomizes VSY Biotechnology's commitment to sustainability in healthcare. By improving patient outcomes, reducing the need for repeat surgeries, and minimizing the environmental impact, this innovative technology stands as a testament to the company's dedication to sustainable medical solutions.

As a game-changing advancement in IOL technology, 100% Glistening-Free IOLs are set to play a central role in the future portfolio of VSY Biotechnology. The company's ongoing dedication to research and development ensures that the benefits of this technology will extend to a broader range of IOL options in its product portfolio, including monofocal EDOF, trifocal, and toric versions of the %100 Glistening-Free Enova® IOL Material.


  1. Glistening Analysis in Enova® Hydrophobic Acrylic Intraocular Lenses / In-vitro Study Evaluating the Tendency of Different Intraocular Lenses to Form Intraoptical Glistenings by the University of Utah

News Source: Ophthalmology Breaking News